Contact
searchSearch
HMP Global

June 2013 - FRMC

Department
Human Insulin Analog to Treat Diabetes
06/26/2013
The FDA approved Humalog® (insulin lispro) in June 1996 to improve glycemic control in adults and children with diabetes. The drug, a rapid acting human insulin analog, is marketed by Eli Lilly and Company. Insulin lispro comes in various...
The FDA approved Humalog® (insulin lispro) in June 1996 to improve glycemic control in adults and children with diabetes. The drug, a rapid acting human insulin analog, is marketed by Eli Lilly and Company. Insulin lispro comes in various...
The FDA approved Humalog®...
06/26/2013
First Report Managed Care
News Connection
Injectable Therapy Receives Expanded Approval for Ulcerative Colitis
06/26/2013
The FDA expanded the approval of Simponi®(golimumab) in May 2013 to treat adults with moderately to severely active ulcerative colitis. The drug, an injectable anti-tumor necrosis factor-alpha treatment from Janssen Biotech, Inc, is also...
The FDA expanded the approval of Simponi®(golimumab) in May 2013 to treat adults with moderately to severely active ulcerative colitis. The drug, an injectable anti-tumor necrosis factor-alpha treatment from Janssen Biotech, Inc, is also...
The FDA expanded the approval of...
06/26/2013
First Report Managed Care
Conference Insider
Pathologic Myopia and Retinal Neovascularization
06/26/2013
Tim Casey
New Orleans—An analysis of a claims database in the United States, which covers >25 million lives annually, found that the incidence of pathologic myopia (PM) was 2.75 per 10,000 individuals in 2011, while the prevalence of PM was 9.64 per...
New Orleans—An analysis of a claims database in the United States, which covers >25 million lives annually, found that the incidence of pathologic myopia (PM) was 2.75 per 10,000 individuals in 2011, while the prevalence of PM was 9.64 per...
New Orleans—An analysis of a...
06/26/2013
First Report Managed Care
Conference Insider
Savings from Preventing Comorbid Conditions in Obese Patients
06/26/2013
Tim Casey
Patients who took the extended release combination of phentermine and topiramate and modified their lifestyle to manage obesity developed fewer comorbidities than they would have without treatment, according to an economic model. 
Patients who took the extended release combination of phentermine and topiramate and modified their lifestyle to manage obesity developed fewer comorbidities than they would have without treatment, according to an economic model. 
Patients who took the extended...
06/26/2013
First Report Managed Care
Conference Insider
Managed Care for Dual-Eligible Population
06/26/2013
Tim Casey
Arlington, Virginia—Of all of the budget issues facing states, among the most pressing is how to pay for healthcare services. States are particularly concerned with providing adequate services and lowering costs of delivering care for dual...
Arlington, Virginia—Of all of the budget issues facing states, among the most pressing is how to pay for healthcare services. States are particularly concerned with providing adequate services and lowering costs of delivering care for dual...
Arlington, Virginia—Of all of...
06/26/2013
First Report Managed Care
Conference Insider
Accountable Care Organizations in Medicaid Programs
06/26/2013
Tim Casey
In order to form advantageous Medicaid accountable care organizations (ACOs), proper methods to combat uncoordinated care must first be established.
In order to form advantageous Medicaid accountable care organizations (ACOs), proper methods to combat uncoordinated care must first be established.
In order to form advantageous...
06/26/2013
First Report Managed Care
Treating Castrate-Resistant Prostate Cancer
06/26/2013
Tim Casey
Orlando—Although the prevalence of prostate cancer is stable, it remains the most common cancer for men. The introduction of new therapies has led to improved survival rates, but most men must take several agents to treat the disease,...
Orlando—Although the prevalence of prostate cancer is stable, it remains the most common cancer for men. The introduction of new therapies has led to improved survival rates, but most men must take several agents to treat the disease,...
Orlando—Although the prevalence...
06/26/2013
First Report Managed Care
Conference Insider
Quality Ratings for Medicare Advantage Plans
06/26/2013
Tim Casey
Orlando—The Centers for Medicare & Medicaid Services (CMS) introduced its 5 Star Ratings system to hold Medicare Advantage plans responsible for delivering improved care and for providing information to patients to make better decisions....
Orlando—The Centers for Medicare & Medicaid Services (CMS) introduced its 5 Star Ratings system to hold Medicare Advantage plans responsible for delivering improved care and for providing information to patients to make better decisions....
Orlando—The Centers for Medicare...
06/26/2013
First Report Managed Care
Conference Insider
Transitioning Toward a Consumer-Centric Approach in Healthcare
06/26/2013
Tim Casey
Orlando—As a partner in Oliver Wyman’s Health & Life Sciences group, Michael Lovdal, PhD, is accustomed to people asking or complaining about the problems associated with healthcare spending. Recently, an acquaintance told him he thought the...
Orlando—As a partner in Oliver Wyman’s Health & Life Sciences group, Michael Lovdal, PhD, is accustomed to people asking or complaining about the problems associated with healthcare spending. Recently, an acquaintance told him he thought the...
Orlando—As a partner in Oliver...
06/26/2013
First Report Managed Care
Evolving Treatment Strategies for Myeloma
06/26/2013
Tim Casey
Orlando—Since 2000, the number of treatments for myeloma has expanded with the introduction of proteasome inhibitors and other immunomodulatory agents. Still, the disease is complex, and there are multiple options available for the treatment...
Orlando—Since 2000, the number of treatments for myeloma has expanded with the introduction of proteasome inhibitors and other immunomodulatory agents. Still, the disease is complex, and there are multiple options available for the treatment...
Orlando—Since 2000, the number...
06/26/2013
First Report Managed Care
Conference Insider
Incidence of Melanoma Continues to Increase
06/26/2013
Tim Casey
Orlando—Between 1985 and 2010, the incidence of melanoma in the United States increased significantly, according to data from the National Cancer Institute. This year, 76,690 people will be diagnosed with, and 9480 people will die from,...
Orlando—Between 1985 and 2010, the incidence of melanoma in the United States increased significantly, according to data from the National Cancer Institute. This year, 76,690 people will be diagnosed with, and 9480 people will die from,...
Orlando—Between 1985 and 2010,...
06/26/2013
First Report Managed Care
Conference Insider
Reducing Use of Antibiotics to Treat Acute Bronchitis
06/26/2013
Tori Socha
  Citing an overuse of antibiotics for acute respiratory tract infections (ARIs) as a contributor to worsening trends in patterns of antibiotic resistance among community-acquired pathogens, researchers recently conducted a study to compare...
  Citing an overuse of antibiotics for acute respiratory tract infections (ARIs) as a contributor to worsening trends in patterns of antibiotic resistance among community-acquired pathogens, researchers recently conducted a study to compare...
  Citing an overuse of...
06/26/2013
First Report Managed Care
Use of Observation Unit and Home Oxygen Therapy to Decrease LOS
06/26/2013
Tori Socha
The most common reason for hospitalization of children <1 year of age in the United States is bronchiolitis, accounting for 150,000 admissions per year with a mean length of stay (LOS) of 3.3 days. Although hospital treatment for...
The most common reason for hospitalization of children <1 year of age in the United States is bronchiolitis, accounting for 150,000 admissions per year with a mean length of stay (LOS) of 3.3 days. Although hospital treatment for...
The most common reason for...
06/26/2013
First Report Managed Care
Pediatric Psoriasis and Excess and Central Adiposity
06/26/2013
Tori Socha
The incidence of psoriasis in children has more than doubled since the early 1970s. The immune-mediated inflammatory skin disease affects 2.5% to 3.5% of the population worldwide and begins during childhood.
The incidence of psoriasis in children has more than doubled since the early 1970s. The immune-mediated inflammatory skin disease affects 2.5% to 3.5% of the population worldwide and begins during childhood.
The incidence of psoriasis in...
06/26/2013
First Report Managed Care
Psoriasis: A Review
06/26/2013
Julia Ernst, MS
  A look at the collaborative efforts that led to the development of the first public health agenda for psoriasis and psoriatic arthritis, along with a review of recent psoriasis research and news. Public Health Agenda for Psoriasis and...
  A look at the collaborative efforts that led to the development of the first public health agenda for psoriasis and psoriatic arthritis, along with a review of recent psoriasis research and news. Public Health Agenda for Psoriasis and...
  A look at the collaborative...
06/26/2013
First Report Managed Care
News Connection
Smoke-Free Workplace Laws and Incidence of MI
06/26/2013
Tori Socha
Previous studies have documented an association between declines in hospital admissions for myocardial infarction (MI) and implementation of smoke-free legislation. A meta-analysis of 17 published studies found a 10% reduction in admissions...
Previous studies have documented an association between declines in hospital admissions for myocardial infarction (MI) and implementation of smoke-free legislation. A meta-analysis of 17 published studies found a 10% reduction in admissions...
Previous studies have documented...
06/26/2013
First Report Managed Care
Conflicts of Interest and Medicaid Drug Selection Committees
06/26/2013
Tori Socha
To ensure that products selected for formularies and reimbursement lists are selected based on evidence without bias, it is important to manage potential conflicts of interest (COI). In the past, according to researchers, physicians who had...
To ensure that products selected for formularies and reimbursement lists are selected based on evidence without bias, it is important to manage potential conflicts of interest (COI). In the past, according to researchers, physicians who had...
To ensure that products selected...
06/26/2013
First Report Managed Care
Variations in Pill Appearance Linked to Adherence with AEDs
06/26/2013
Eileen Koutnik-Fotopoulos
Despite the clinical bioequivalence between branded and generic drugs, findings of a nested case-control study showed changes in pill color significantly increased the odds of nonpersistence among patients taking antiepileptic drugs (AEDs)...
Despite the clinical bioequivalence between branded and generic drugs, findings of a nested case-control study showed changes in pill color significantly increased the odds of nonpersistence among patients taking antiepileptic drugs (AEDs)...
Despite the clinical...
06/26/2013
First Report Managed Care
News Connection
Primary Care-Based Diabetes Prevention Interventions Reduce BMI
06/26/2013
Eileen Koutnik-Fotopoulos
Using the Diabetes Prevention Program (DPP) model, a study of 2 different lifestyle interventions delivered in a primary care setting showed a reduction in body mass index (BMI) in overweight or obese adults with prediabetes, metabolic...
Using the Diabetes Prevention Program (DPP) model, a study of 2 different lifestyle interventions delivered in a primary care setting showed a reduction in body mass index (BMI) in overweight or obese adults with prediabetes, metabolic...
Using the Diabetes Prevention...
06/26/2013
First Report Managed Care
News Connection
Clinician Communication Skills and Medication Adherence
06/26/2013
Tori Socha
Patients with diabetes mellitus, who are at high risk for cardiovascular morbidity and mortality, are often prescribed hypoglycemic, antihypertensive, and lipid-lowering medications. The success of this therapy depends on a high rate of...
Patients with diabetes mellitus, who are at high risk for cardiovascular morbidity and mortality, are often prescribed hypoglycemic, antihypertensive, and lipid-lowering medications. The success of this therapy depends on a high rate of...
Patients with diabetes mellitus,...
06/26/2013
First Report Managed Care
Reducing Frequency of Pediatric Headaches
06/26/2013
Mary Mihalovic
It is estimated that 15% of children and adolescents suffer from tension headaches and 4% from migraines.
It is estimated that 15% of children and adolescents suffer from tension headaches and 4% from migraines.
It is estimated that 15% of...
06/26/2013
First Report Managed Care
News Connection
Antiretroviral Therapy Adherence Improved with Managed Problem Solving
06/26/2013
Tori Socha
The progression of treatable chronic diseases depends on patient adherence to pharmacotherapy.
The progression of treatable chronic diseases depends on patient adherence to pharmacotherapy.
The progression of treatable...
06/26/2013
First Report Managed Care
Risk of Heart Disease among HIV-Positive Veterans
06/26/2013
Tori Socha
Due to the success of treatment with antiretroviral therapy (ART), people with HIV live longer, but are at risk for heart disease, according to researchers. Previous studies have found an association between HIV and acute myocardial...
Due to the success of treatment with antiretroviral therapy (ART), people with HIV live longer, but are at risk for heart disease, according to researchers. Previous studies have found an association between HIV and acute myocardial...
Due to the success of treatment...
06/26/2013
Veterans Health Today
News Connection
Pediatric 30-Day Readmission Rates and Variability across Hospitals
06/26/2013
Tori Socha
One measure of quality of hospital care patients receive during inpatient treatment used by clinicians, hospitals, patients, health systems, and purchasers of healthcare is the rate of readmission within 30 days of discharge. 
One measure of quality of hospital care patients receive during inpatient treatment used by clinicians, hospitals, patients, health systems, and purchasers of healthcare is the rate of readmission within 30 days of discharge. 
One measure of quality of...
06/26/2013
First Report Managed Care
News Connection
Medigap Enrollment Steady, Premiums on the Rise
06/26/2013
Jill Sederstorm
Medigap continues to be an important source of supplemental coverage for Medicare recipients, with the most popular plans being those that offer first-dollar coverage. This was just one of the many conclusions drawn from a recent Kaiser...
Medigap continues to be an important source of supplemental coverage for Medicare recipients, with the most popular plans being those that offer first-dollar coverage. This was just one of the many conclusions drawn from a recent Kaiser...
Medigap continues to be an...
06/26/2013
First Report Managed Care
Brain Reward Abnormalities and Antipsychotic Monotherapy in Schizophrenia
06/26/2013
Alice Brindle
Research has linked schizophrenia to dysfunction of dopamine neurotransmission and the brain reward system. It is possible that a dysregulated hyperdopaminergic state may lead to the development of psychoses through altered reward processing....
Research has linked schizophrenia to dysfunction of dopamine neurotransmission and the brain reward system. It is possible that a dysregulated hyperdopaminergic state may lead to the development of psychoses through altered reward processing....
Research has linked...
06/26/2013
First Report Managed Care
Smoking Cessation, Weight Change, and CVD Risk
06/26/2013
Tori Socha
Cigarette smoking is also a major risk factor for cardiovascular disease (CVD) and the leading cause of preventable death in the United States. The risk of CVD can be greatly reduced by smoking cessation, but cessation is also associated with...
Cigarette smoking is also a major risk factor for cardiovascular disease (CVD) and the leading cause of preventable death in the United States. The risk of CVD can be greatly reduced by smoking cessation, but cessation is also associated with...
Cigarette smoking is also a...
06/26/2013
First Report Managed Care
News Connection
Physician Prescribing Behavior Not Affected by FFS Model
06/26/2013
Tori Socha
Studies have identified the fee-for-service (FFS) model of physician reimbursement as a driver of healthcare resource utilization, including possible overtesting and overtreatment, according to researchers from Cardinal Health Specialty...
Studies have identified the fee-for-service (FFS) model of physician reimbursement as a driver of healthcare resource utilization, including possible overtesting and overtreatment, according to researchers from Cardinal Health Specialty...
Studies have identified the...
06/26/2013
First Report Managed Care
News Connection
Cost Reduction, Quality Improvement, and Reimbursement Increases
06/26/2013
Tori Socha
Oncology clinical pathways are evidence-based treatment regimens for the treatment of breast, lung, and colon cancers.
Oncology clinical pathways are evidence-based treatment regimens for the treatment of breast, lung, and colon cancers.
Oncology clinical pathways are...
06/26/2013
First Report Managed Care
Cancer Screening Cessation for Older Adults
06/26/2013
Tori Socha
There are many educational efforts designed to increase the rates of screening for cancer, which is an important part of standard medical care. However, the balance of the risks and benefits of screening are affected by situations such as...
There are many educational efforts designed to increase the rates of screening for cancer, which is an important part of standard medical care. However, the balance of the risks and benefits of screening are affected by situations such as...
There are many educational...
06/26/2013
First Report Managed Care
FDA Creates Breakthrough Designation for Drugs
06/26/2013
Tim Casey
From October 1, 2012, to May 31, 2013, the FDA received 51 requests for breakthrough therapies. The agency granted 19 of the requests and denied 14 of them. In each case, the FDA reviewed the requests within 60 days of receipt.
From October 1, 2012, to May 31, 2013, the FDA received 51 requests for breakthrough therapies. The agency granted 19 of the requests and denied 14 of them. In each case, the FDA reviewed the requests within 60 days of receipt.
From October 1, 2012, to May 31,...
06/26/2013
First Report Managed Care
News Connection
Clinical Pathways As Care Model
06/26/2013
Tim Casey
Bruce Feinberg, DO, initially participated in a program focused on standardizing care for cancer patients in 1994. As the founder of Georgia Cancer Specialists, a group of oncologists based in Atlanta, he implemented a system in which...
Bruce Feinberg, DO, initially participated in a program focused on standardizing care for cancer patients in 1994. As the founder of Georgia Cancer Specialists, a group of oncologists based in Atlanta, he implemented a system in which...
Bruce Feinberg, DO, initially...
06/26/2013
First Report Managed Care

Behind the Bill

Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care
BEHIND THE BILL
When Agencies Lose Power: How 3 Seismic Shifts are Transforming Pharmaceutical Regulation
05/07/2025
Katie Hayes, MJ
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months,...
05/07/2025
First Report Managed Care
Behind the Bill
The Medicare Paradox, Part 3: Strategic Trade Doesn’t Have to be a Zero-Sum Game
05/07/2025
Katie Hayes, MJ
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve...
05/07/2025
First Report Managed Care

Trending Articles

Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consul...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, h...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
News
Debate Emerges Over FDA's Plan to Regulate Laboratory Medical Tests
05/03/2024
Hannah Musick
The FDA's new regulations on laboratory-developed tests have sparked debate over access to innovative tests and patient care in the medical field, with opponents arguing that increased oversight could hinder the development of crucial new...
The FDA's new regulations on laboratory-developed tests have sparked debate over access to innovative tests and patient care in the medical field, with opponents arguing that increased oversight could hinder the development of crucial new...
The FDA's new regulations on...
05/03/2024
First Report Managed Care
Interview
Key Pharmaceutical Pipeline Developments: Insights from Industry Experts
05/29/2024
Learn about promising drugs currently in the pharmaceutical pipeline and the impact of FDA interventions from presenters at AMCP 2024.
Learn about promising drugs currently in the pharmaceutical pipeline and the impact of FDA interventions from presenters at AMCP 2024.
Learn about promising drugs...
05/29/2024
First Report Managed Care
News
‘Hidden’ Signs May Signal Subclinical Progression in Early MS
07/15/2024
Jolynn Tumolo
Focusing solely on relapse rates and magnetic resonance imaging (MRI) lesion activity to track disease progression in patients with early multiple sclerosis (MS) may miss indicators of subclinical disease activity, with important implications...
Focusing solely on relapse rates and magnetic resonance imaging (MRI) lesion activity to track disease progression in patients with early multiple sclerosis (MS) may miss indicators of subclinical disease activity, with important implications...
Focusing solely on relapse rates...
07/15/2024
First Report Managed Care

June 2013 Volume 10 Issue 6

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use